The mechanism of development of a thromboembolism during these procedures is not quite clear. The fact cannot be denied that local activation of a coagulation process, particularly in its platelet link, takes place after thermal damage of the endocardial surface and its microcirculation system and subsequent occurrence of necrotic materials. The extent of this activation depends on the size of the damage, on the body's response, and other inhibitory and stimulating factors (8). Procedure outcomes developing on this timescale are diverse and individualized and have different clinical expressions (9).
INTRODUCTION
Radiofrequency catheter ablation (RFA) is a widely applied and effective method of treatment of various cardiac arrhythmias. However, its employment is limited by complications, including thromboembolic ones, which occur more frequently when RFA is applied in the left atrium (LA). Post-RFA thromboembolic complications were reported in <0.2% (1) of children and in 0.6% to 1.3% of adults (2, 3) ; if RFA is applied in the LA it is 1.8% to 2%, in the case of ventricular tachycardia it is up to 2.8%, (4) and while treating atrium fibrillation, 5% to 10.3% (5) (6) (7) . The results of major databases show the lack of attention to these complications after RFA.
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There are early and late post-RFA thromboembolic complications. The early complications are caused by local hemostatic disruption in the catheter zone and the late ones by endothelial damage (2) (these develop later). Clot formation within the first week after RFA is evaluated by experiments applying histological methods.
There have been many inconclusive discussions as to whether embolization prevention with coagulation system modulating (usually suppressing) medications (antiplatelet drugs and/or anticoagulants) is beneficial. Clinical studies regarding this are precariously few.
The purpose of this article is to determine how RFA affects platelet aggregation in the early period after the procedure, whether aggregation intensity depends on the RFA total energy (TE) for one patient, and how it is influenced by the illness.
STUDIES ON HUMANS
Studies on humans were carried out according to the principles of the Declaration of Helsinki. Informed consent was obtained from all patients, and the study was approved by the Regional Bioethics Committee of Kaunas University of Medicine (2004-12-21 Nr. 150/2004).
We examined 97 cases of cardiac arrhythmias (atrial flutter, supraventricular tachycardia, or extrasystolia). The main diagnosis of a case was based on clinical and electrophysiological test data. Summarized clinical characteristics of all patients are given in Table 1 .
RFA Procedure and Assay Scheme
Patients had no meal and did not smoke 12 to 16 hours before the RFA. The RFA procedure was performed using the standard Seldinger puncture method. Through the puncture of the right femoral vein or artery, multicontact electrodes were inserted into the heart and directed to certain cardiac areas with an accuracy of 1 to 2 mm. Their electrical activity and the spread of the impulse were registered in the intracardiac electrocardiogram (ECG) by the computer system (PRUCKA Engineering, Inc. Cardiolab 4.0; General Electrics; USA). The arrhythmogenic substrate was destroyed using radiofrequency of 500 kHz with 30 to 60 W energy, which produces a temperature of 50ºC to 70ºC, irreversibly coagulating 2 to 4 mm 3 size of tissue at the side where a special destructive electrode-catheter contacts the endocardium. After this procedure, patients have to lie in a horizontal position for 4 hours and cannot flex the leg whose vessel was cathetered.
All the patients were analyzed 3 times: before RFA, 1 hour after RFA, and 24 hours after the procedure.
METHODS

Preparation of Blood
The blood for platelet aggregation testing was drawn from the antecubital vein into a 4.5 mL vacuum test tube with 3.8% sodium citrate. Plateletrich plasma (PRP) was separated from red blood cells by blood centrifuging at 1000 rpm (111g) (12) for 15 minutes at room temperature. Platelet-poor plasma was obtained by further centrifuging the rest of the blood at 3000 rpm (1006g) for 30 minutes. The time from taking blood until aggregation analysis did not exceed 60 minutes.
Platelet Aggregation
PA was analyzed in PRP using an aggregometer (CHRONO-LOG, USA) based on platelet plasma optical density variation in the process of aggregation, expressed in relative percentages. ADP (3.6 μmol/L), epinephrine (4.5 μmol/L), and collagen (2 μg/mL) were used for aggregation induction. We used several different agonists for better evaluation of PA-determining receptor activity because platelets could be stimulated through different receptor systems.
Statistical Analysis
Statistical calculations were carried out using the statistical packages Excel and SPSS 12.0 for Windows. All data are presented as mean ± SD. Student's t test for paired variables was used for statistical comparison in groups of patients.
RESULTS
Platelet aggregation of all patients treated by RFA is presented in Fig. 1 . We determined that ADP-induced PA significantly decreased by 5% (P < .005) whereas epinephrine-induced PA significantly decreased by 8.9% (P < .001) after RFA. In 24 hours after RFA, both agonist-induced PA increased, respectively, to 2.6% and 3%, returning to the pre-RFA levels.
The dynamics of collagen-induced PA differed timewise from the influence of other agonists. PA of all patients tended to decrease (0.2%) after RFA and continued in 24 hours (2.6%).
Different total energies are needed to eliminate diverse arrhythmias. Three groups of patients were formed based on the TE used for RFA: group A with 26 patients with TE < 4000 J, group B with 35 patients with TE from 4000 to 15 000 J, and group C with 36 patients with TE > 15 000 J. Table 2 presents the results obtained. Alterations of ADP-and collagen-induced PA essentially did not depend on TE right after RFA. However, PA induced by epinephrine in group A remained unchanged after RFA, whereas in groups B and C, it decreased significantly, respectively, by 8.1% (P < .05) and 16.8% (P < .01) of pre-RFA levels. In 24 hours, epinephrine-induced PA decreased by 12.9% (P < .05) in group A, whereas in groups B and C it increased by 4.6% and 14.6% (P < .05), respectively.
Alterations of ADP-and epinephrine-induced PA in the group with least TE (A group) during RFA differed from that in groups B and C. In group A with low TE, PA decreased soon after and in 24 hours after RFA. Meanwhile, in groups B and C where the TE was large, PA decreased right after RFA and increased 24 hours after RFA. The results obtained show that epinephrine-induced PA after RFA depends on the TE used. TE inversely correlated with epinephrine-induced PA right after RFA (r = −0.44, P < .001), whereas other correlations of TE with PA were weak and nonsignificant.
While analyzing the alteration of PA in terms of the cause of arrhythmia, all patients were classified into 4 groups: 1-supraventricular tachycardia; 2-ischemic heart disease; 3-arterial hypertension; 4-valvular disease ( Table 1) . Data of PA induced by different agonists in these groups are presented in Table 2 .
We did not find significant differences between separate groups based on the cause of arrhythmia. However, we observed different dynamics of PA before, after, and in 24 hours after RFA for different groups. For instance, in the valvular disease group, ADP and epinephrine-induced PA had a tendency to decrease after RFA.
DISCUSSION
All patients had an uneventful RFA procedure. In this study, we tried to detect how RFA influences PA, whether the TE of RFA might affect the intensity of aggregation, and what influence the heart pathology causing arrhythmia had on PA.
It is known that in the normal body state or in the presence of minor tissue injury, a declining hemostatic physiological function does not manifest clinically, and dynamic balance is preserved between activating and suppressing hemostatic mechanisms; that is, activation of hemostasis develops in parallel with fibrinolysis. Antithrombogenic properties of blood vessels (factors excreted from the endothelium, increased blood flow, etc) inhibit platelet adhesion to the intact walls. New facts have emerged about factors that can directly or indirectly have an influence by suppressing the coagulation system during injury to the endothelium. Yoshimoto et al examined the effect of extracellular and intracellular NO on collagen-induced whole blood aggregation and platelet activation in whole blood. They found that intracellular generation of NO inhibited whole blood aggregation, and this mechanism might have an important role because of its antithrombotic effect in whole blood (13) .
In experiments on pigs, antiplatelet properties of endocardial endothelial cells (EECs) and coronary artery endothelial cells (CECs) have been evaluated. It has been found that EECs had stronger antiplatelet action than CECs, and they inhibit PA more through PGI2 but not through NO. As this antiaggregation property was significantly greater in EECs than in CECs, it has been presumed that endocardial endothelial PGI2 might inhibit the formation of both the intracardiac and the intracoronary artery thrombus (14) .
On the other hand, a new regulator of endothelial proinflammatory activation, identified as Kruppellike factor 2 (KLF 2) has been discovered. KLF2 maintains the antiplatelet properties of the endothelium, strongly inducing thrombomodulin and endothelial NO synthase expression and reducing plasminogen activator inhibitor-1 (PAI-1) expression (15) .
Our study demonstrated decreased PA after the RFA procedure, and this change could be explained by intensive mobilization of anticoagulant system factors.
While discussing these problems, we should also address the multiple effects of RFA: hemocoagulation changes while inserting the catheters, direct thermal effect on surrounding tissues, and endothelial damage in all stages of the procedure.
Comparing RFA and the intracardial electrophysiological test (iEPT), it was seen that RFA had a higher complication rate than iEPT (3.1%:1.1%), and the complication rate among elderly people was more than that for younger people for both iEPT (2.2%:0.5%) and RFA (6.1%:2.0%) (10) .
During the RFA procedure, transesophageal echocardioscopy documented a spontaneous post-RFA echogenicity (16) (17) (18) . However, failure to detect thrombi at the site of ablation might be because of minor RFA damages and massive blood flow at this site (14) . Although treatment with anticoagulants was used while performing intracardiac echocardiography in the LA during RFA for treating atrial fibrillation, LA macroreentrant tachycardia thrombus formation was observed in 10.3% of all patients on the transseptal catheter sheath (6) . Maintaining continuous perfusion through the transseptal sheath at a rate of 3 mL/h, 6% of the patients developed cerebral thromboembolic complications, whereas using a high-flow rate of 180 mL/h, the risk was 17 times lower (19) .
As we examined peripheral vein blood PA 1 hour after RFA, we found that ADP-and epinephrineinduced PA decreased, but in 24 hours after RFA it tended to return to pre-RFA levels. In contrast, PA induced by collagen did not change after RFA; however, it tended to decrease 24 hours later. Other authors found increases in ADP-and collagen-induced PA 10 min after RFA in blood taken from the central vessels, the ascending aorta, and pulmonary artery, and these parameters returned to the original level 30 min after RFA (20) . Michelucci and others (3) noted a significant post-RFA increase in spontaneous PA in whole blood, and PRP returned to the original level in 24 hours. It seems that the impact of RFA on PA depends on the time of investigation, the agonists used for PA, and the physical characteristics of the radiofrequency energy used. So the mechanism of post-RFA thromboembolism remains unclear. In the majority of cases, authors emphasize the activation of the coagulation system in the early and late post-RFA stages. Increased levels of coagulation activation markers prothrombin 1+2 fragments, thrombin-antithrombin complex, (2, 3, 21, 22) beta-thromboglobulin (22) , and thromboxane B2 concentration (20) have been found at the end of the RFA procedure, which returned to normal in 24 hours after RFA. The markers of fibrinolysis system, D-dimers (3, 21, 22, 23) , and plasminogen activator 3 remained increased 24 hours after RFA even when antiaggregants (aspirin or ticlopidin) were administered 3 days before RFA (24) . When using anticoagulants, the D-dimer concentration was found to be lower than that for untreated patients (25) .
Results provided in the literature about RFA effects on platelet function are controversial. The data we obtained demonstrated a decrease or minor change in PA during 1 hour after the RFA procedure. In the presence of marked tissue damage, this change could be explained by intensive mobilization of antithrombotic system factors (NO, PGI2). Further tests are needed to determine what follows a few days after RFA, to determine the mechanism of post-RFA thromboembolism, and to assess the necessity and validity for its prophylaxis with one or several right antiplatelet medicines depending on the platelet sensitivity. We should take into consideration the fact that on the platelet surface, various receptors may be activated; therefore, inhibition of only 1 receptor cannot secure the expected therapeutic effect. Although the number of post-RFA thromboembolism cases is not high, some patients do suffer from it and, therefore, the question about preventive measures should not be neglected.
